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Abstract: Diets rich in (poly)phenols are associated with a reduced reduction in the incidence of
cardiovascular disorders. While the absorption and metabolism of (poly)phenols has been described,
it is not clear how their metabolic fate is affected under pathological conditions. This study evaluated
the metabolic fate of berry (poly)phenols in an in vivo model of hypertension as well as the associated
microbiota response. Dahl salt-sensitive rats were fed either a low-salt diet (0.26% NaCl) or a
high-salt diet (8% NaCl), with or without a berry mixture (blueberries, blackberries, raspberries,
Portuguese crowberry and strawberry tree fruit) for 9 weeks. The salt-enriched diet promoted
an increase in the urinary excretion of berry (poly)phenol metabolites, while the abundance of
these metabolites decreased in faeces, as revealed by UPLC–MS/MS. Moreover, salt and berries
modulated gut microbiota composition as demonstrated by 16S rRNA analysis. Some changes in
the microbiota composition were associated with the high-salt diet and revealed an expansion of
the families Proteobacteria and Erysipelotrichaceae. However, this effect was mitigated by the dietary
supplementation with berries. Alterations in the metabolic fate of (poly)phenols occur in parallel with
the modulation of gut microbiota in hypertensive rats. Thus, beneficial effects of (poly)phenols could
be related with these interlinked modifications, between metabolites and microbiota environments.
Keywords: polyphenols; cardiovascular; dysbiosis; gut metabolism; high salt intake
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1. Introduction
Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for more
than 17 million deaths, meaning that more people die annually from CVDs than from any other
cause [1]. CVDs are a group of disorders affecting the heart and blood vessels, and include diseases
and/or syndromes such as atherosclerosis and hypertension, ischemic coronary and heart diseases,
myocardial infarction, and heart failure [1,2]. Most of these diseases are heterogeneous conditions
with diverse aetiologies and comorbidities, generally aggravated by age and risk factors such as family
history, gender, tobacco and alcohol consumption, unhealthy diet, physical inactivity, cholesterol, and
hypertension. Due to their prevalence and their anticipated increase in the next decade [1], the study of
CVDs and the search for better treatments have become an increasing focus of interest for the academic
and pharmaceutical sectors.
Cardiovascular health is affected by alterations in human dietary and lifestyle patterns. A high
salt intake is associated with an increased risk of hypertension and cardiovascular diseases [3–5]. It has
been estimated that excess sodium intake was responsible for 1.7 million deaths from cardiovascular
causes globally in 2010 [5]. For a long time, the deleterious effects associated with high salt consumption
were only related to the effect of salt on blood pressure (BP) [6–8]. However, numerous other effects
have been reported, such as endothelial dysfunction, stroke, ventricular hypertrophy and fibrosis,
arterial and ventricular stiffening, myocardial infarction, arrhythmias, and heart failure [6].
Several epidemiological studies have suggested an association between (poly)phenol-enriched
diets (fruits and vegetables) and a lower risk of CVDs [9]. Berries are among the fruits with higher
(poly)phenol content and, although limited, there is data supporting their recommendation as an
essential part of a diet beneficial to the heart [10].
Through the years, intervention studies have investigated the effects of different berries (i.e.,
blackcurrants, bilberries, blueberries, chokeberries, cranberries, lingonberries, raspberries, strawberries
among others) in healthy human subjects or in subjects with CVD risk factors. Reviewed by [10].
The underlying mechanisms for these beneficial effects are believed to include the upregulation of
endothelial nitric oxide synthase (eNOS), decreased oxidative stress, the attenuation of inflammatory
gene expression including the reduction of inducible nitric oxide synthase (iNOS) and foam cell
formation [10,11]. A significant reduction in CVD mortality, associated with strawberry intake, during
a 16 year follow-up period was observed in post-menopausal women. Moreover, for strawberries and
blueberries, the significant reduction in the relative risk was associated with at least once per week
consumption [12]. Moreover, specific berries, such as bilberry and blackcurrant extracts, chokeberry
juice, cranberry extracts, and freeze-dried strawberries were shown to have favourable effects on
plasma glucose or lipid profiles in subjects with metabolic risk factors including type 1 or type 2
diabetes mellitus, dyslipidemia, or metabolic syndrome [13–16]. These studies ranged in duration
from 4 to 12 weeks and used conventional berry products or purified anthocyanin extracts, suggesting
that both these forms of delivery are effective.
Regarding the effects in blood pressure, trials conducted using different varieties of fresh and
processed berry products, showed a significant decrease in systolic blood pressure; in healthy men
following cranberry juice supplementation [17]; in subjects with CVD risk factors following mixed
berry supplementation [18]; and in postmenopausal women with pre- and stage 1 hypertension
following daily blueberry and strawberry consumption for 8 weeks [19,20]. However, the cellular
processes and molecular targets of berries (poly)phenols remain to be identified, and therefore there is
a need for more studies of berry supplementation as a potential dietary therapy for the management of
pre-hypertension or hypertension.
We recently demonstrated the beneficial effects of berry-enriched diet ingestion in a chronic model
of hypertension-induced heart failure, the Dahl salt-sensitive (Dahl/SS) rats, and underpin possible
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molecular targets [21]. The berry mixture provided to the rats prolonged the lifespan, maintained the
body weight, ameliorated systolic blood pressure (SPB) and cardiac function and decreased cardiac and
renal hypertrophy of rats fed a high-salt diet [21]. The study clearly supports the modulation of cystein
and glycin-rich protein 3 (CSRP3) involved in myocyte cytoarchitecture, by the (poly)phenol-rich
berry diet as an efficient cardioprotective strategy in hypertension-induced heart failure. Yet, it was
not clarified how berry’s (poly)phenols metabolism was affected under these pathological conditions.
The elucidation of how they are absorbed, metabolised, and eliminated from the body is crucial to
ascertain their in vivo actions.
(Poly)phenol metabolites can be absorbed in the stomach, small intestine, or in the colon [11].
However, their bioavailability in humans is very low. In the upper gastrointestinal tract, the absorption
starts with cleavage of the sugar moiety and diffusion of the aglycone to the enterocytes. Before
entering systemic circulation, (poly)phenols may undergo phase II metabolism reactions (the formation
of glucuronic, sulphate, and/or methyl derivatives). Phenolic compounds that are not absorbed in the
small intestine will reach the colon, where they are extensively metabolised by the colonic microbiota
into a series of simple phenolic metabolites [11]. These metabolites, being absorbable, may be the ones
responsible for the health benefits derived from (poly)phenols-rich food consumption, rather than the
parent compounds per se, which are underrepresented in circulation [11,22–24]. Conversely, phenolic
compounds are described to modulate gut microbiota by the inhibition of pathogenic bacteria and the
stimulation of beneficial bacteria. This bidirectional relationship may contribute to host health benefits,
although the mechanisms are not fully understood [11,22,25,26].
Until now, only few bacterial species (e.g., Escherichia coli, Bifidobacterium sp., Lactobacillus sp.,
Bacteroides sp., and Eubacterium sp.) have been identified as responsible for the catabolism of the
phenolic compounds and their pathways [27]. Thus, the effect of dietary (poly)phenols on the
modulation of the gut microbiota, including the underlying mechanisms and the actual benefits of
such bioactive compounds, remains poorly understood. Moreover it is not clear how the composition
of the gut microbiota is modulated not only in healthy individuals, but also under a disease status,
thereby providing a link between bioactive metabolites of (poly)phenols and their health benefits [28].
This work aims to address this knowledge gap by providing evidence of the metabolic fate
of dietary (poly)phenols, in a rat model of hypertension where we previously described that they
developed elevated systolic blood pressure (SPB), cardiac dysfunction and hypertrophy [21], as
well as evaluating alterations in the model’s gut microbiota composition by this (poly)phenol rich
diet in the context of hypertension. In this work, the metabolic fate of (poly)phenols in an animal
model of hypertension (Dahl/SS rats) was evaluated using a quantitative analysis of tissues, liver
and heart, and also blood, urine and faeces revealing that a high-salt diet exerts an influence in the
excretion of (poly)phenol metabolites. Both dietary salt content and berry consumption induced
changes in the gut microbiota, for example berry consumption was associated with an expansion of
the phylum Bacteroidetes and a decrease in Firmicutes in both low-salt (LS) and high-salt (HS) diets.
Interestingly, Proteobacteria were elevated in the HS diet, but berry consumption led to a reduction in
their abundance.
2. Experimental Section
2.1. Chemicals and Reagents
Standards of catechol, (−)-epicatechin, (+)-catechin, (−)-epigallocatechin, (−)-epigallocatechin-3
-O-gallate, gallic acid, 4-O-methylgallic acid, p-hydroxybenzoic acid, protocatechuic acid, 2-(phenyl)
acetic acid, 3-(4-hydroxyphenyl)propionic acid, p-coumaric acid, ferulic acid, ellagic acid, caffeic aid,
gallic acid, protocatechuic acid, dihydromyricetin, eriodictyol, 7-hydroxyflavonol, myricetin, quercetin,
kaempferol, cyanidin and morin were purchased from Sigma Aldrich (Dorset, UK) or Extrasynthese
Ltd. (Genay, France).
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The procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin], 2-(2-hydroxyphenyl) acetic acid,
2-(4-hydroxyphenyl) acetic acid and 3-(2,4-dihydroxyphenyl)propionic acid were purchased from
Fluka Co. (Buchs, Switzerland). The 4-O-methylgallic acid sulphate, catechol sulphate, pyrogallol
sulphate, 4-O-methylcatechol sulphate, vanillic acid sulphate, and 1-O-methylpyrogallol sulphate
were chemically synthetised in collaboration with Dr. Rita Ventura as previously published [29].
The reagents formic acid, ethyl acetate, sulphuric acid, hydrochloric acid, sodium hydroxide, petroleum
ether, cellulase (EC 3.2.1.4) and hesperidinase (EC 3.2.1.40) from Aspergillus niger were purchased from
Sigma-Aldrich (St. Louis, MO, USA).
The acetonitrile (HPLC-grade), methanol (HPLC-grade), acetone (HPLC-grade) and glacial acetic
acid (99.8%) were of analytical grade (Scharlab, Barcelona, Spain or JT Baker brand (Scientific Chemical
Supplies, UK)). Ortho-phosphoric acid 85% was purchased from MontPlet and Esteban S.A. (Barcelona,
Spain). L-(+)-ascorbic acid (reagent grade) was provided by Scharlau Chemie (Barcelona, Spain).
Ethanol was purchased from Carlo Erba (Laborspirit, Lda. Lisbon, Portugal). Sodium acetate was
purchased from Merck (Darmstadt, Germany). Ultrapure water was obtained from a Milli-Q water
purification system (Millipore Corp., Bedford, MA, USA).
2.2. Preparation and Characterization of Diets
2.2.1. Fruit Puree (Berry Mixture)
The fruit puree consisted of equal parts of five fruits (3.7 kg): southern highbush blueberries
(Vaccinum corymbosum L. variety Georgia Gem), blackberries (Rubus L. subgenus Rubus Watson variety
Karaka Black) and raspberries (Rubus idaeus L. variety Himbo Top) were harvested at the Fataca
experimental field in Odemira, Portugal; strawberry tree fruits (Arbutus unedo L.) were harvested
in the Alentejo region, Portugal and Portuguese crowberries (Corema album L.) were harvested in
the Comporta region, Portugal. Fruits were blended together using a domestic food processor at
room temperature. The resulting puree was freeze-dried and stored at −20 ◦C until further use.
Detailed identification and semi-quantification of (poly)phenols in the fruit purée has been described
previously [30]. These have been analysed by HPLC–MS, as it is reported in Section 2.2.5.
2.2.2. Low-Salt and High-Salt diets
Rat powder chow (50 g) was prepared fresh every day by mixing the regular AIN-76a (INRA
UPAE, Jouy-en Josas, France) with or without a lyophilised berry mixture: (1) a low-salt diet enriched
with 0.26% NaCl (LS); (2) a low-salt diet enriched with 0.26% NaCl and supplemented with 2 g
of lyophilised berry mixture (LSB); (3) a hypersaline diet enriched with 8% NaCl (HS); and (4) a
hypersaline diet enriched with 8% NaCl, and supplemented with 2 g of lyophilised berry mixture
(HSB).
2.2.3. Determination of Proximate Composition
The proximate composition of the feeds (LS, LSB, HS and HSB) was determined based on the
standard methods of the Association of Official Analytical Chemists (AOAC) [31]. The water content
was determined by drying at 103 ± 2 ◦C to a constant mass. Ashes content was obtained by drying at
550 ± 50 ◦C for 6 h. Total nitrogen was obtained by Kjeldahl method [32]: digestion with sulphuric acid
at 410 ◦C for 40 min, followed by distillation with sodium hydroxide and titration with hydrochloric
acid. To obtain crude protein, total nitrogen content was multiplied by a conversion factor of 6.25.
Crude fat content was determined by extraction with petroleum ether in a Soxhlet apparatus for 60
min, followed by solvent evaporation at 103 ± 2 ◦C to a constant mass. Crude fibre was determined
according to Weende method as described by AOAC [31], by digesting the sample in refluxing 1.25%
sulphuric acid (30 min), followed by 1.25% sodium hydroxide (30 min). After digestion, samples were
dried at 105 ◦C for 1 h and heated at 550 ◦C for 3 h. Carbohydrates were calculated by difference
(subtracting water, ashes, protein, fats and fibres).
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2.2.4. Enzymatic Hydrolysis of Glycosides
Enzymatic hydrolysis of glycosides was performed according to Pimpão et al. (2013) [30] with
slight adjustments. Briefly, phytochemicals were extracted by homogenizing 2.5 g of lyophilised berry
mixture, LS, LSB, HS and HSB diets with 7.5 mL of methanol/0.2% acetic acid containing 0.05 mg/mL
of morin as internal standard. Samples were vortexed and shaken for 30 min at room temperature in
the dark. The mixture was then centrifuged at 12400× g for 10 min at room temperature. Supernatants
were filtered through a 0.2 µm Teflon (PTFE) filter followed by drying under a nitrogen flow and stored
at −80 ◦C until further use.
Samples for aglycone analysis were reconstituted in water with 1 mM ascorbic acid, and then
adjusted to pH 3.8 with 0.2 M acetate buffer and incubated for 16 h at 40 ◦C with 0.02 U/mL hesperidinase
[1 unit (U) corresponds to 333 mg of protein and is defined as the amount required to liberate 1.0 µmol
of glucose from hesperidin per minute at pH 3.8 at 40 ◦C]. The pH was then increased to 5.0 with
sodium acetate, and cellulase was added to a final concentration of 20 U/mL (1 U corresponds to
0.885 mg of protein and is defined as the amount required to liberate 1.0 µmol of glucose from cellulose
for 1 h, at pH 5.0 at 37 ◦C). Samples were incubated for 4 h at 37 ◦C and then extracted three times with
ethyl acetate. The ethyl acetate phase (containing phenolic aglycones) was separated and evaporated
with a nitrogen flow, then the dried samples were reconstituted with 14 mL of 0.1% (w/v) formic acid
solution in acetonitrile/water (1:1) and filtered through a 0.2 µm PTFE filter prior to HPLC–MS analysis.
The procedure was performed in triplicate for each diet.
2.2.5. HPLC–MS Analysis of (Poly)Phenols from Diets
Hydrolysed and non-hydrolysed lyophilised berry mixture and diets were analysed by HPLC–MS.
The analysis was conducted on an Accela 600 HPLC system (Thermo Scientific, Bremen, Germany)
using a 150 × 2 mm C18 Synergi Hydro RP18 with 4 µm particle size (Phenomenex, Macclesfield, UK)
fitted with a security Guard system containing Aqua 10 m and C18 Guard cartridge (2 mm × 4 mm).
The elution gradient was achieved with dH2O with 0.1% formic acid (solvent A) and acetonitrile
with 0.1% formic acid (solvent B). The gradient program used started with 2%B and held for 2 min,
increased to achieve 5%B at 5 min, 45%B at 25 min and 100%B at 26 min. The gradient was held at
100% for 3 min, subsequently brought back to 2%B by 30 min, and then held this gradient for 5 min.
Analysis was performed on an LTQ Orbitrap XL hybrid mass spectrometer (Thermo Scientific, Bremen,
Germany). The electrospray ionization (ESI) settings were as follows: the capillary temperature was
380 ◦C with sheath gas at 35 psi and auxiliary gas at 15 psi. For the positive polarity, the source voltage
was set at 4.50 kV, source current at 110 µA, capillary voltage at 44.00 V and tube lens voltage at 120 V.
For negative polarity, the source voltage was set at 3.50 kV, source current at 100 µA, capillary voltage
at −44.00 V and tube lens voltage at −100.00 V. The MS analysis was performed using data-dependent
Nth order double play analysis comprising a full scan mass range 80–2000 amu, 30,000 resolution
data-type profile and data-dependent MS/MS on the top five most intense peaks (signal threshold of
600,000 and 300,000 counts in positive and negative mode, respectively). MS data handing software
(Xcalibur Qualbrowser and QuantBrowser, Thermo Electron Corp) was used to search for metabolites
and their appropriate m/z values and perform semiquantitative analysis of target compounds. All peaks
were checked for m/z value, retention time and fragmentation products for identification purposes.
Based on an initial qualitative analysis of the dataset a targeted list of compounds was selected for
semi-quantification using total areas of selected ion chromatograms. Principal Component Analysis
(PCA) was used to summarise broad scale variation among hydrolysed and non-hydrolysed samples
in both positive and negative modes. Analysis of variance was performed to compare high salt vs. low
salt in berry diets individually for hydrolysed and non-hydrolysed datasets as well as ESI positive and
ESI negative datasets. Statistical analysis was performed on GenStat for Windows version 15.3.0.9425
(VSN International Ltd., Hemel Hempstead, UK).
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2.3. Animals
Male Dahl/SS rats (obtained from Charles River) weighing 169 ± 7 g were used in the experiments.
Forty animals were housed two per cage in a temperature (22 ± 1 ◦C) and humidity (55 ± 10%)
controlled room with a 12 h light/dark cycle (lights on at 08:00 h). The experiments were performed
during the light period. Food and water were available ad libitum in both the home and metabolic cages.
After 1 week of acclimatization, rats were divided into 4 groups for ten weeks. Rats were fed a
AIN-76a powder chow (INRA UPAE, Jouy-en Josas, France) with or without berry mixture and with
two levels of salt content, low or high (LS, LSB, HS, HSB).
For the collection of urine and faeces, the rats were allocated one per metabolic cage for 4 days,
with a 24 h adaptation period before urine and faeces collection in the 4th and 9th week. After collection,
urine was centrifuged at 3000× g for 5 min at 7 ◦C. A total of 500 µL of urine was acidified with 100 µL
of Milli-Q water/formic acid (50/50, v/v). Samples were stored at −20 ◦C until further analysis. Faeces
were frozen in liquid N2 immediately after collection and stored at −80 ◦C until further analysis.
At the end of the experiment, animals were sacrificed by decapitation without any anaesthetic
previously prescribed. Blood was collected and centrifuged at 2000× g for 10 min to obtain plasma.
Fifty µL of 10 mM ascorbic acid solution prepared in 50% Milli-Q water/formic acid (v/v) was added
to 1 mL of plasma to limit oxidation and acidify the solution. Samples were stored at −20 ◦C until
further analysis.
Different tissues (liver and heart) were excised from the rats, frozen in liquid N2 immediately
after collection followed by storage at −80 ◦C until further use.
The Ethical Committee of the University of Paris-Sud, France approved all animal research
protocols (N◦APAFIS#2152-2015092912128144 v3). All animal care and experimental procedures were
performed according to the European Community guiding principles in the care and use of animals
(Directive 2010/63/EU of the European Parliament) and authorizations to perform animal experiments
according to this directive were obtained from the French Ministry of Agriculture, Fisheries and Food
(No. D-92-283, 13 December 2012) All studies involving rats are reported in accordance with the
Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines for reporting experiments
involving animals.
2.4. Plasma, Urine, Faeces and Tissues Treatment
In order to clean up the biological matrix and pre-concentrate the phenolic compounds, a
pre-treatment with microelution solid-phase extraction (µSPE) was used for plasma and urine [33–35].
Regarding faeces and tissues (liver and heart), they were sequentially pre-treated by a combination of
liquid–solid extraction (LSE) and SPE [36]. The methodologies were followed according to previous
publications [37].
2.4.1. Plasma Samples
For plasma, 350 µL of the sample was combined with 350 µL of phosphoric acid (4%) and
centrifuged at 8784× g for 10 min (Hettich Universal 320-R, Tuttlingen, Germany). The collected
supernatant was pre-treated by µSPE as described in previous studies [33,34]. Briefly, the
micro-cartridges OASIS HLB µElution Plates 30 mm (2 mg) (Waters, Milford, MA, USA) were
conditioned sequentially by using 250 µL of methanol and 250 µL of 0.2% of acetic acid, and then
the sample was loaded onto the plate. The loaded plates were washed with 200 µL of Milli-Q
water and 200 µL of 0.2% acetic acid. Then, the retained phenolics were eluted with 2 × 50 µL of
acetone/Milli-Q water/acetic acid solution (70/29.5/0.5, v/v/v). The eluted solution was directly injected
into the chromatographic system.
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2.4.2. Urine Samples
For urine, 100 µL of the sample was mixed with 50 µL of catechol (20 mg/L) as internal
standard (it was prepared with phosphoric acid at 4%), followed by centrifugation at 8784× g for
10 min. The supernatants were collected, and an aliquot of the extract was pre-treated by µSPE.
The micro-cartridges were conditioned sequentially with 250 µL of methanol and 250 µL of 0.2% of
acetic acid. Then, the retained phenolic compounds were eluted with 2 × 50 µL of acetone/Milli-Q
water/acetic acid solution (70/29.5/0.5, v/v/v) and directly analysed into the chromatographic system.
2.4.3. Faecal Samples
For faecal samples, a liquid–solid extraction was carried out by adding 1 mL of methanol/Milli Q
water/HCl (79.9/20/0.1, v/v/v) to 100 mg of lyophilised faeces. The samples were vortexed for 10 min at
room temperature. The samples were then centrifuged twice (10 min, 8784× g, at room temperature)
and the resultant supernatant was filtered with a 0.22 µm nylon syringe filter and transferred into
chromatographic vials for analysis.
2.4.4. Tissues Samples (Liver and Heart)
Briefly, for the analysis of the tissues, 60 mg of freeze-dried liver and 50 mg of heart were mixed
with 50 µL of ascorbic acid (1%), and 150 µL of phosphoric acid (4%). Each sample was extracted four
times with 400 µL of extraction solution (Milli-Q water/methanol/phosphoric acid 4%; 94/4.5/1.5, v/v/v).
The samples were then sonicated (S-150D Digital SonifierR Cell Disruptor, Branson, Ultrasonidos
S.A.E., Barcelona, Spain) for 30 s, maintaining the sample in an ice water bath, and then centrifuged for
15 min at 8784× g at 20 ◦C.
Aliquots of the extracts were pre-treated by SPE (OASIS HLB 3 cc (60 mg) from Waters, Milford,
MA, USA) in order to clean up and pre-concentrate the sample before chromatographic analysis.
Briefly, the cartridges were conditioned sequentially by using 5 mL of methanol and 5 mL of 0.2%
acetic acid. Then, 1.4 mL of the tissue extracts was loaded, and the loaded cartridges were washed
with 3 mL of Milli-Q water and 3 mL of 0.2% of acetic acid. Finally, the elution of the retained phenolic
compounds was performed with 4 mL of acetone/Milli-Q water/acetic acid solution (70/29.5/0.5, v/v/v).
Then, the samples were dried under a nitrogen stream. Phenolic compounds were dissolved with
100 µL of the extraction solution, acetone/Milli-Q water/acetic acid solution (70/29.5/0.5, v/v/v), and
analysed into the chromatographic system as previously described [34,38].
2.5. Analysis of Berries Metabolites by UPLC–ESI-MS/MS
The analysis of berry metabolites in the plasma, urine, faeces and tissues was performed
using a UPLC coupled to tandem MS (MS/MS). The chromatographic system is an AcQuity
Ultra-PerformanceTM liquid chromatography and tandem MS from Waters (Milford MA, USA),
as reported in a previous study [36]. The column was an Acquity UPLCTM BEH C18 (100 × 2.1 mm
i.d., 1.7 µm), also from Waters (Milford MA, USA). Two gradients with different mobile phases
were used—one for the analysis of anthocyanin metabolites and a second one for the analysis of the
remaining phenolic compound metabolites. For the analysis of anthocyanin metabolites, the mobile
phase was 10% acetic acid as solvent A, and acetonitrile as solvent B. The flow rate and gradient
elution is the reported in our previous study [34]. Briefly, the flow rate was 0.4 mL/min, and the
gradient elution was as follows: 0–10 min, 5%–35%B; 10–10.10 min, 35%–80%B; 10.10–11 min, 80%B
isocratic; 11–11.10 min, 80%–5%B; 11.10–12.50 min, 5% B isocratic. Regarding the analysis of the rest
of the phenolic metabolites, the mobile phase was 0.2% acetic acid as solvent A and acetonitrile as
solvent B, and the flow rate was 0.4 mL/min. The gradient elution is as follows: 0–5 min, 5%–10
B%; 5–10 min, 10%–12.4%B; 10–18 min, 12.4%–28%B; 18–23 min, 28%–100%B; 23–25.5 min, 100%B;
25.5–27 min, 100%–5%B; and 27–30 min, 5%B. The injection volume was 2.5 µL.
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The AcQuity UPLCTM system was coupled to a PDA detector, and a triple quadrupole detector
(TQDTM) mass spectrometer (Waters). The software used was MassLynx 4.1. Ionization was performed
by electrospray (ESI) in the positive mode for the analysis of anthocyanins, and in negative mode
for the remaining phenolic compounds. The ionization source parameters were the reported in a
previous study [33–35]. The phenolic metabolites derived from berry intake were quantified by using
the selected reaction monitoring (SRM) mode. Two transitions were acquired and the most sensitive
was used for quantification and the second one for identification purposes. Supplementary Table S1
information shows these SRM transitions used for quantification and identification as well as their
cone voltage and collision energy.
2.6. 16S rRNA Gene Sequencing Analysis of Gut Microbiota
DNA from primary stool samples were extracted as previously described by Frémont et al. [39].
A normalised quantity of 50 ng of extracted DNA (measured by the Quant-iT PicoGreen dsDNA
Assay Kit from Thermo Fisher (Merelbeke, Belgium)) was used for each sample. The 16S rRNA genes
were amplified using the S-D-Bact-0341-b-S-17/S-D-Bact-0785-a-A-21 primer pair [40] targeting the
amplification of the V3 and V4 hypervariable 16S rRNA gene regions. The 16S Metagenomic Sequencing
Library Preparation protocol from Illumina (Part # 15044223 Rev. B) was followed, including the
quality controls. The sequencing was carried out on Miseq sequencing machine (Illumina, San Diego,
California, USA) with a read length of 2 × 300 nt.
The diversity metrics were calculated using the vegan package in R. Operational taxonomic unit
(OTU) tables were subsampled to slightly below the smallest library (30,000 reads) for alpha and
beta diversity comparisons. For alpha diversity, OTU richness and Shannon diversity indices were
calculated. For beta diversity, Bray–Curtis distance was used for Principal Coordinate Analysis and the
clustering of samples was evaluated using analysis of similarity (ANOSIM). Statistical significance of
factors shaping the microbiota was determined using permutational multivariate analysis of variance
(perMANOVA). Identification of differentially abundant taxa was performed with analysis of variance
(ANOVA). P-values were corrected for multiple comparisons using the false discovery rate method.
2.7. Short Chain Fatty Acids (SCFAs) Analysis
SCFAs (C2–C8 fatty acids, including isoforms C4–C6) were analysed in faeces, and performed
according to Andersen et al. [41]. Briefly, overnight lyophilization was carried out while protecting
samples from light. Afterwards, SCFA extraction was carried out with diethyl ether and quantified by
gas chromatography (GC-2014, Shimadzu®, ’s-Hertogenbosch, The Netherlands) using a DB-FFAP
123-3232 column (30 m× 0.32 mm× 0.25µm; Agilent, Machelen, Belgium) and a flame ionization detector
(FID). Liquid samples were conditioned with sulphuric acid, sodium chloride and 2-methyl hexanoic
acid as internal standard for quantification of further extraction with diethyl ether. The prepared
sample (1 µL) was injected at 280 ◦C, with a split ratio of 60:1 and a purge flow of 3 mL/min. The oven
temperature gradient increased by 6 ◦C/min from 110 ◦C to 158 ◦C and by 8 ◦C/min from 158 ◦C to
175 ◦C, where it was kept for 1 min using nitrogen as carrier gas at a flow rate of 2.49 mL/min. FID was
carried out at 220 ◦C.
2.8. Statistical Analysis
Results are expressed as the mean concentrations (nmol in urine and nmol/g fresh material in
faeces) ± Standard Error of Means (SEM). The non-parametric Kruskal–Wallis and Dunn’s tests were
applied to analyse significant differences (p < 0.05) between groups. The Kruskal–Wallis test was
applied to determine whether any significant difference between the treatments were detected. Dunn’s
test was subsequently used to compare all the significantly different pairs of the treatments. The Prism
7 for Mac OS X, version 7.0a was used.
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3. Results
3.1. Nutritional Composition of the Diets and Berry Mixture
The proximate compositions of the diets, as well as the berry mixture were determined
(Supplementary Tables S2 and S3). The analysis revealed that the dominant components for the
LS, LSB, HS and HSB diets are carbohydrates, water and proteins with no statistical differences between
samples. The addition of the berry mixture does not alter the nutritional value of the diets.
3.2. (Poly)Phenols Content in Diets
Food matrices can interact with (poly)phenols altering their bioavailability. To ensure that the
differences observed in polyphenol metabolism of the animals, are not related with food matrix effects,
we assessed whether the high-salt content in the diets had an influence in the (poly)phenol content
extracted from the berries or on the release of (poly)phenols from the food matrix after digestion.
The analysis of intact, non-hydrolysed LS, LSB, HS and HSB diet extracts by HPLC–MS revealed
a great complexity and diversity of compounds particularly in the diets supplemented with berries
(Supplementary Tables S4 and S5, and supplementary Figure S1).
To further analyse the impact of salt in the (poly)phenol composition derived from berries, and
to maximise the analysis of the differences observed among the samples, the HPLC–MS data was
processed by means of Principal Component Analysis (PCA, Supplementary Figure S2). All the
diets clustered according to the presence or absence of berries in the diet (Supplementary Figure
S2A, PC 1, 92.67%). LS and HS diet samples without berries are clustered together (Supplementary
Figure S2A), which demonstrate that the presence of berries in the diet clearly is the main determinant
that distinguish the diets. No effect of the salt is evidenced in (poly)phenol composition. Analysis of
variance revealed that there were no significant differences (p < 0.05) between non-hydrolysed berry
diets containing low salt and non-hydrolysed berry diets containing high-salt diets in both ESI positive
and negative mode datasets (Supplementary Tables S4 and S5).
The content of anthocyanins in our berry mixture was evaluated since it is described as the
major (poly)phenol class represented in the mixture (Supplementary Table S6). Cyanidin glucoside
(1053± 87.90 mg/kg) was the main anthocyanin quantified in the extract obtained from the berry mixture,
followed by delphinidin glucoside (915 ± 64.40 mg/kg), petunidin glucoside (913 ± 68.10 mg/kg)
and malvidin glucoside (859 ± 63.10 mg/kg). The less abundant anthocyanins were the ones in the
acetylglucoside form. Overall, in each 2 g of lyophilised berry mixture added daily to the rat’s diet,
9.47 mg in total of anthocyanins were incorporated. The main aglycones of the remaining (poly)phenols
in the berry mixture were also estimated after enzymatic hydrolysis (Supplementary Table S7), being
phenolic acids, the major components followed by flavonols and flavanols.
3.3. Analysis of Aglycones after Enzyme Hydrolysis of Glycosides
In order to understand whether the presence of the salt affects the release of the aglycones from the
food matrix, and in a certain way, to predict possible effects that occurred during the gastro-intestinal
digestion of the Dahl/SS rats, we decided to analyse diets after enzymatic digestion. Extracts from the
diets (LS, LSB, HS and HSB) and the berry mixture were incubated with enzymes from Aspergillus niger:
hesperidinase containing α-l-rhamnosidase and β-d-glucosidase activities and cellulase containing
endo-1,4-β-d-glycosidic activity. We used the same strategy as for the non-hydrolysed samples, samples
were analysed by HPLC–MS, and data was processed by means of a PCA. Supplementary Figure S2B
shows, again, that the presence of berries in the diets is responsible for the differences between the
samples (PC 1 88.28%, clusters) and that salt does not affect the release of the aglycones. ANOVA
showed that for the positive mode (Supplementary Table S8), there is only one metabolite, out of 144,
that is significantly different between LSB and HSB (Unknown 12 C17H19NO9). Regarding the negative
mode (Supplementary Table S9), only two metabolites (out of 96) appear to be significantly different
between HSB and LSB, gallic acid isomer 1 and syringetin isomer 1, indicating that the presence of salt
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does not affect significantly the release of the phenolic aglycones. Representative chromatograms of the
positive and negative mode of the HPLC–MS analysis are presented in the supplementary Figure S3.
3.4. Beneficial Effects of Berries against Chronic Salt Consumption
Recently, our group demonstrated the beneficial effects of the berry-enriched diet used in this
trial in the Dahl/SS rats [21]. The goal of this preceding publication was to characterise how this berry
mixture protected Dahl salt-sensitive rats from salt-induced cardiovascular damage [21]. No animals
from LS and LSB groups died during the trial while in the HS group, mortality reached 40% with rats
dying predominantly from stroke. A positive effect of the berry-enriched diet on survival became
statistically significant from 6 weeks (p < 0.05) until the end of the study, leading to 30% lower animal
death in the group with the HS diet supplemented with berries (p < 0.05). During the study, no
significant differences either in survival rate or body weight gain were observed between LS and LSB
rats (Supplementary Figure S4A). In contrast, we observed a significant loss of body weight in the HS
rats from 7 weeks (Supplementary Figure S4A). This weight loss was significantly prevented by berry
consumption until the end of the trial (Supplementary Figure S4A). Systolic blood pressure (SBP) in HS
rats was significantly higher compared to LS animals at 3, 6 and 9 weeks, confirming the deleterious
effect of salt on SBP and validating the experimental hypertension model (Supplementary Figure S4B).
The SBP of LSB rats tended to be higher at 6 weeks, but after 9 weeks, no differences were found in
comparison to LS rats. Interestingly, berries alleviated the development of hypertension induced by
HS diet after 3 and 6 weeks. However, SBP of HS rats decreased at 9 weeks and thereby, reached the
level of HSB rats (Supplementary Figure S4B). Taken all together, a HS diet promotes animal death,
decreases body weight and increases hypertension, while the consumption of berries reverted these
deleterious events. Thus, our berry-enriched diet showed cardiovascular protective properties.
3.5. Metabolic Fate of (Poly)Phenols
We assessed the metabolic fate of (poly)phenols after the chronic ingestion of the berry-enriched
diet for 9 weeks and evaluated the persistence of these metabolites in the organism. Moreover, we
aimed to understand whether the metabolic fate of (poly)phenols was affected by the high blood
pressure induced by the salt enriched diet. The experiment was not designed as a multi-component
pharmacokinetic study, and rats were fasting overnight, approximately for 16 h. With this approach,
we were not able to identify any (poly)phenol metabolites in heart, liver, and plasma, indicating that
they do not persist in these organs and fluids after 16 h (data not shown).
Food intake was monitored, and no differences were observed between animals with the different
diets. The animal’s food intake was between 77% and 86% of the food supplied in the 4th week, with a
reduction to 44%–66% at 9 weeks, but again with no significant differences within the groups (data not
shown). Regarding water intake, there was a significant increase in rats consuming a HS diet with or
without berry supplementation. The water intake in these animals was approximately 2.5 times higher
at week 4 and approximately 3 times higher at week 9 of the trial (data not shown) when compared
with rats fed a low-salt diet.
3.5.1. Urinary (Poly)Phenols Excretion
A total of 44 urinary (poly)phenol metabolites were identified and quantified by UPLC–MS/MS
(Tables 1 and 2). Table 1 shows the concentration data of 22 metabolites that are present in all rats
independently of the diet at 4 and 9 weeks of trial and, therefore, their presence is not specific due
to the berry supplementation. However, the levels of most of the metabolites are affected by the
supplementation with berries.
Hippuric acid, as expected, was the most abundant phenolic acid in urine samples in the
4 groups and was significantly higher in rats that consumed a berry enriched diet (p < 0.001) (Table 1).
Interestingly, 4-methyl catechol glucuronide and pyrogallol sulphate were excreted at 4 weeks, but do
not appear in urine at the end of the trial (9 weeks). In fact, the major alterations due to the introduction
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of the salt in the diet were observed at 4 weeks. Further, 3-(hydroxyphenyl) propionic acid sulphate
and 3-(4-hydroxyphenyl) propionic acid were present in high levels in rats that ingested the berry
mixture during the trial. Interestingly, at 4 weeks, the rats consuming the HSB diet excreted even more
of both compounds. Conversely, pyrogallol sulphate, a minor compound present in urine of LS and
LSB rats at week 4, exhibited much higher excretion in hypertensive animals where salt is introduced
in the diet. In fact, there is a trend for increasing excretion of most of the metabolites (54%) after the 4th
week of the introduction of the salt in the diet. However, at week 9, this increase was only observed for
22% of the metabolites. The exceptions were ferulic acid and dihydroferulic acid derivatives, which
exhibited a reduced excretion after introduction of the salt.
Of the 44 metabolites identified, half were only excreted in urine of rats with LSB and HSB
diet (Table 2). Gallic acid, gallic acid glucuronide, vanillic acid glucuronide, syringic acid, syringic
acid sulphate and 5-(dihydroxyphenyl)-γ-valerolactone glucuronide metabolites (Table 2) were only
identified in the urine of LSB rats and were absent in that of HSB rats which means that the presence of
high amounts of salt in the diet affects their excretion.
Coumaric acid glucuronide was the only metabolite to be exclusively excreted in urine of HSB
rats at 4 (1.8 ± 1.0 nmol) and 9 (5.8 ± 1.5 nmol) weeks of diet (Table 2).
For almost half (45%) of the metabolites detected in LSB rats, there was a trend of higher excretion
at the end of the trial compared to week 4. This was in contrast to the observations in HSB animals,
where only 15% of the metabolites were more excreted at the end of the trial. This reflects an association
between the presence of the salt in the diet with the development of any impairment associated to
the hypertension.
Unsurprisingly, anthocyanins were only identified and quantified in the urine samples of the
animals with diets supplemented with berries (Figure 1). For the most abundant anthocyanins
(cyanidin glucoside, delphinidin glucoside, petunidin glucoside and malvidin glucoside), there was no
detectable difference in the excretion in the hypertensive animals due to the presence of salt in the
diet. As previously mentioned, cyanidin glucoside was the main anthocyanin quantified in the extract
obtained from the berry mixture and was also the main anthocyanin to be excreted in the urine of LSB
and HSB rats.
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Table 1. (Poly)phenol metabolites in urine of rats fed a low salt (LS), low-salt supplemented with 2g of lyophilised berry mixture (LSB), high salt (HS) and high-salt
supplemented with 2g of lyophilised berry mixture (HSB) at 4 and 9 weeks of trial. Results expressed in nmol as the mean ± SEM of values at 4 and 9 weeks of diet for
six rats in the LS and LSB groups, for eight rats in the HS group and 12 rats in the HSB group.
4th Week 9th Week
LS LSB HS HSB LS LSB HS HSB
Benzoic Acid Derivatives
Vanillic acid sulphate 15.3 ± 3.2 94.5 ± 7.4 6.9 ± 3.3 294.0 ± 21.4 ### 88.6 ± 35.9 276.0 ± 37.2 64.7 ± 27.8 288.0 ± 32.3 #
Protocatechuic acid sulphate 1 51.8 ± 11.7 54.0 ± 8.8 605 ± 200 779 ± 217 90.6 ± 42.4 247.0 ± 48.7 1038 ± 120 ** 702.0 ± 75.6
Hydroxybenzoic acid 1 32.7 ± 7.6 73.5 ± 10.6 206.0 ± 22.1 *** 313.0 ± 23.0 $$$ 134.0 ± 44.6 84.2 ± 25.8 173 ± 9.5 230 ± 34.7 $$$
Hydroxybenzoic acid sulphate 1 n.d. n.d. 2.58 ± 1.2 72.0 ± 8.1 $$$## 6.2 ± 3.6 n.d. 138.0 ± 36.7 * 145.0 ± 14.9 $$$
Cinnamic Acid Derivatives
Coumaric acid sulphate 1 1.8 ± 0.6 117.0 ± 11.7 * 18.1 ± 2.3 329.0 ± 32.2 ## n.d. 687 ± 143 *** 27.1 ± 3.3 679.0 ± 63.2 ###
Caffeic acid sulphate 1 7.0 ± 1.3 57.8 ± 5.0 *** n.d. 143.0 ± 6.5 $$$### 10.1 ± 3.5 130 ± 20.5 *** n.d. 147.0 ± 8.6 ###
Caffeic acid glucuronide 1 1.13 ± 0.09 7.6 ± 0.9 n.d. * 13.3 ± 3.9 # n.d. 10.0 ± 2.2 ** n.d. 13.0 ± 3.4 #
Ferulic acid 10.4 ± 0.8 31.8 ± 2.6 7.59 ± 1.76 61.9 ± 5.1 ### 9.4 ± 2.4 19.5 ± 3.8 n.d. 1.9 ± 0.8 $
Ferulic acid sulphate n.d. 31.2 ± 3.2 ** 4.48 ± 2.43 35.9 ± 13.9 n.d. 87.1 ± 6.3 *** n.d. 32.0 ± 7.8 #
Ferulic acid glucuronide 0.65 ± 0.34 20.7 ± 1.5 *** n.d. 4.2 ± 1.4 # n.d. 38.4 ± 7.8 *** n.d. 2.4 ± 0.8 $
Catechol Derivatives
Catechol sulphate n.d. 11.4 ± 7.1 436.0 ± 49.6 * 781.0 ± 55.4 $$$ n.d. 730 ± 158 ** 312 ± 55.4 1161 ± 175 $#
4-methyl catechol sulphate 1 6.4 ± 2.9 4.7 ± 1.0 n.d. 22.6 ± 4.6 ### 19.8 ± 5.4 60.2 ± 8.4 21.1 ± 8.1 52.1 ± 7.8
4-Methyl catechol glucuronide 1 352 ± 111 221.0 ± 27.6 n.d. *** 240.0 ± 29.5 ### n.d. n.d. n.d. n.d.
Pyrogallol Derivatives
Pyrogallol sulphate 1 40.2 ± 14.3 2.1 ± 1.3 576 ± 76.4 ** 215 ± 33.9 $$ n.d. n.d. n.d n.d.
Hippuric Acid Derivatives
Hippuric acid 734.0 ± 60.1 4225 ± 226 *** 1494 ± 96.0 13416 ± 937 ### 702 ± 135 4693 ± 332 * 862 ± 73.4 10609 ± 864 ###
Propionic Acid Derivatives
3-(Hydroxyphenyl)propionic acid glucuronide 1 n.d. 0.09 ± 0.09 n.d. n.d. n.d. 5.4 ± 0.8 *** 5.4 ± 0.8 0.04 ± 0.04 $$$
3-(4-hydroxyphenyl) propionic acid 2 36.5 ± 3.5 572 ± 75.5 177 ± 98.1 1357 ± 240 ## 4.16 ± 1.84 1347 ± 312 *** 15.7 ± 6.5 2068 ± 757 ###
3-(Dihydroxyphenyl) propionic acid 1 0.8 ± 0.2 14.5 ± 1.5 n.d. 137 ± 13.0 ### n.d. 30.3 ± 4.7 31.5 ± 14.1 138 ± 25.4 ###
3-(Hydroxyphenyl)propionic acid sulphate 1 7.7 ± 1.7 206.0 ± 24.7 18.9 ± 4.9 1536 ± 180 ### 7.7 ± 1.7 1842 ± 336 ** 32.2 ± 8.2 2975 ± 299 ###
Dihydroferulic acid 3.8 ± 0.3 19.7 ± 2.7 n.d. 2.1 ± 1.1 $$$ 3.1 ± 1.2 16.2 ± 1.9 0.16 ± 0.16 58.2 ± 10.7 ###
Dihydroferulic acid sulphate 3.3 ± 0.2 46.2 ± 5.8 ** n.d. * 5.6 ± 1.8 $$ n.d. 52.5 ± 9.1 *** n.d. 24.2 ± 5.5 ##
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Table 1. Cont.
4th Week 9th Week
LS LSB HS HSB LS LSB HS HSB
Flavanols Derivatives
Methyl catechin glucuronide 1 1.1 ± 0.7 651.0 ± 54.4 *** n.d. 528 ± 108 ### n.d. 961 ± 138 *** n.d. 407 ± 39.8 ###
* p < 0.05, ** p < 0.01, *** p < 0.001 versus LS; $ p < 0.05, $$ p < 0.01, $$$ p < 0.001 vs. LSB; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. HS; n.d.: not detected; 1 it is possible to have more than one
isomer for this compound that is not possible to distinguish by the MS/MS; 2 identity confirmed by standard.
Table 2. (Poly)phenol metabolites identified exclusively in urine of rats fed a LSB and HSB diet at 4 and 9 weeks of trial. Results are represented in nmol as the
mean ± SEM of values at 4 and 9 weeks of diet for six rats in the LS and LSB groups, for eight rats in the HS group and 12 rats in the HSB group.
4th Week 9th Week
LSB HSB LSB HSB
Benzoic Acid Derivatives
Vanillic acid 40.1 ± 12.7 n.d $ 85.9 ± 17.8 *** 19.0 ± 7.9 $
Vanillic acid glucuronide  7.3 ± 2.4 *** n.d. $$$ n.d. n..d
Gallic acid  n.d. n..d 12.4 ± 7.3 ** n.d. $$$
Gallic acid glucuronide  1 n.d. n.d. 20.2 ± 8.6 *** n.d. $$$
4-O-methylgallic acid 88.6 ± 7.7 ** 97.5 ± 8.7 ### 127.0 ± 10.7 *** 80.7 ± 13.3 $##
4-O-methylgallic acid sulphate 38.7 ± 6.7 139.0 ± 11.8 ### 177.0 ± 36.5 ** 204.0 ± 17.1 ###
Syringic acid  15.8 ± 1.7 *** n.d. $$$ 21.8 ± 2.2 *** n.d. $$$
Syringic acid sulphate  2.5 ± 0.3 *** n.d. $$$ 9.6 ± 0.8 *** n.d. $$$
Cinnamic Acid Derivatives
Coumaric acid 1 18.7 ± 2.6 79.9 ± 6.8 ### 99.5 ± 18.7 ** 99.9 ± 8.1 $$$
Coumaric acid glucuronide  1 n.d. 1.8 ± 1.0 n.d. 5.8 ± 1.5 $$###
Phenylacetic Acids Derivatives
2-(Dihydroxyphenyl)acetic acid 1 2.1 ± 0.8 n.d. 5.4 ± 1.1 *** 4.9 ± 2.5
2-(Trihydroxyphenyl)acetic acid 1 31.9 ± 4.0 *** 25.6 ± 4.5 ### 33.7 ± 4.5 ** 26.5 ± 5.9 ##
Catechol Derivatives
Catechol glucuronide n.d. 165.0 ± 7.9 $$$### 46.8 ± 27.6 129.0 ± 21.7 $$$###
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Table 2. Cont.
4th Week 9th Week
LSB HSB LSB HSB
Valeric Acid Derivatives
5-(Hydroxyphenyl)valeric acid 1 2.8 ± 1.0 ** n.d. $$ 6.1 ± 2.2 *** 0.62 ± 0.44 $$
Valerolactone Derivatives
5-(Dihydroxypheny)l-γ-valerolactone 1 0.43 ± 0.22 n.d. 5.0 ± 1.2 * 17.1 ± 4.4 ###
5-(Dihydroxyphenyl)-γ-valerolactone sulphate 1 2.7 ± 0.9 3.1 ± 1.0 13.9 ± 1.2 ** 23.3 ± 5.8 ###
5-(Dihydroxyphenyl)-γ-valerolactone glucuronide  1 n.d. n.d. 0.97 ± 0.57 *** n.d. $$$
Flavanols Derivatives
Catechin glucuronide 1 105.0 ± 9.8 *** 110.0 ± 19.3 ### 180 ± 19.4 *** 159.0 ± 24.1 ###
Methyl-O-catechin sulphate 1 0.24 ± 0.11 3.6 ± 1.8 8.7 ± 1.4 2.4 ± 1.2
Epicatechin glucuronide 1 56.4 ± 6.5 * 77.6 ± 11.0 ### 96.3 ± 23.9 ** 99.2 ± 9.9 ###
Methyl-O-epicatechin sulphate 1 14.2 ± 2.7 51.4 ± 12.0 ### 30.2 ± 2.5 ** 37.0 ± 13.2
Methyl-O-epicatechin glucuronide 1 114.0 ± 17.5 *** 67.7 ± 14.5 # 221 ± 73.1 *** 67.3 ± 19.2
 Metabolites exclusively excreted in urine of LSB rats.  Metabolites exclusively excreted in urine of HSB rats. * p < 0.05, ** p < 0.01, *** p < 0.001 versus LS; $ p < 0.05, $$ p < 0.01,
$$$ p < 0.001 vs. LSB; # p < 0.05, ## p < 0.01, ### i < 0.001 vs. HS.; n.d.: not detected; 1 it is possible to have more than one isomer for this compound that is not possible to distinguish by the
MS/MS.
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Figure 1. Anthocyanins identified exclusively in urine of rats fed a LSB and HSB diet at 4 and 9 weeks of trial. Results are represented (nmol) as the mean ± SEM of values at 4 
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Figure 1. Anthocyanins identified exclusively in urine of rats fed a LSB and HSB diet at 4 and 9 weeks of trial. Results are represented (nmol) as the mean ± SEM of
values at 4 and 9 weeks of diet for six rats in the LSB group and 12 rats in the HSB group.
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3.5.2. Faecal (Poly)Phenol Excretion
The analysis of faecal (poly)phenol metabolites revealed a total of 30 metabolites which were
identified and quantified by UPLC–MS/MS (Tables 3 and 4). Further, 2-(Phenyl) acetic acid,
2-(hydroxyphenyl) acetic acid and hippuric acid were the most abundant metabolites found in
faeces samples from LS and LSB rats at weeks 4 and 9 of the diet. Interestingly, vanillic acid, vanillic
acid sulphate, gallic acid sulphate and caffeic acid were only identified in LS and LSB rats in the 4th
week of trial.
Table 4 shows the metabolites that were only excreted by rats that consumed a diet supplemented
with berries. Protocatechuic acid was only identified at week 4 in the faeces of rats with LSB and HSB
diets, whereas 3-(dihydroxyphenyl)propionic acid was only identified in LSB samples at the end of
the trial. Further, 4-O-methylgallic acid was another metabolite exclusively excreted in LSB samples.
However, it was present at both weeks 4 and 9 of the experiment.
In the animals exposed to high salt in their diets, there was a reduction in the levels of(poly)phenol
metabolites excreted. This trend was observed in rats with a HS diet at weeks 4 and 9 of the trial.
Moreover, the rate of excretion, independently of the presence of salt, was smaller at week 9 compared
to week 4.
A total of 15 anthocyanins (Figure 2) were identified and quantified rats with diets supplemented
with berries, and in much higher amounts than those found in urine samples. Cyanidin glucoside,
cyanidin rutinoside, delphinidin glucoside, delphinidin arabinoside and malvidin glucoside were the
major anthocyanins excreted, but there were no detectable differences in the excretion between the
control animals and the ones with salt-induced hypertension.
Although some of the metabolites detected could be derived from direct absorption and conjugation
of (poly)phenols present in the berry mixture, most of those present in urine and faecal samples are
derived from gut microbial metabolism. Based on these results, a putative metabolic pathway of berry
(poly)phenols after ingestion of a berry-enriched diet for 9 weeks and based in the metabolites excreted
was developed (Figure 3).
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Table 3. (Poly)phenol metabolites identified in faeces of the rats fed a LS, LSB, HS and HSB diet at 4 and 9 weeks of trial. Results expressed in µmol/kg fresh faeces as
the mean ± SEM of values at 4 and 9 weeks of diet for six rats in the LS and LSB groups, for eight rats in the HS group and 12 rats in the HSB group.
4th Week 9th Week
LS LSB HS HSB LS LSB HS HSB
Benzoic Acid Derivatives
Vanillic acid 1.3 ± 0.8 4.3 ± 1.7 ** n.d. n.d. n.d. n.d. n.d. n.d.
Vanillic acid sulphate 3.7 ± 1.6 4.1 ± 1.8 n.d. ** n.d. $ n.d. n.d. n.d. n.d.
Gallic acid 16.6 ± 6.2 102.0 ± 25.1 n.d. 10.7 ± 0.8 ### 0.79 ± 0.55 12.5 ± 4.3 0.77 ± 0.49 3.5 ± 0.4
Gallic acid sulphate 1 48.9 ± 27.9 33.1 ± 14.6 n.d. ** n.d. $ n.d. n.d. n.d. n.d.
4-O-methyl gallic acid sulphate 1.2 ± 0.7 5.0 ± 2.3 n.d. n.d. $ n.d. 0.06 ± 0.05 n.d. n.d.
Protocatechuic acid sulphate 1 8.0 ± 3.1 3.5 ± 1.4 n.d. *** n.d. 0.32 ± 0.12 0.35 ± 0.14 n.d. n.d.
Hydroxybenzoic acid 1 40.2 ± 15.3 17.7 ± 5.2 3.2 ± 1.2 3.6 ± 1.0 4.5 ± 1.2 4.4 ± 1.4 0.37 ± 0.24 3.5 ± 1.8
Hydroxybenzoic acid sulphate 1 51.2 ± 29.4 31.8 ± 12.2 ** n.d. 0.10 ± 0.07 $$ 0.00 ± 0.00 0.52 ± 0.26 n.d. n.d.
Cinnamic Acid Derivatives
Coumaric acid 1 3.5 ± 0.8 4.8 ± 1.9 0.34 ± 0.10 0.40 ± 0.07 n.d. 0.41 ± 0.15 n.d. 0.12 ± 0.08
Coumaric acid sulphate 1 14.1 ± 7.9 54.2 ± 19.9 n.d. ** 2.1 ± 0.5 # n.d. 2.2 ± 0.6 * n.d. 1.4 ± 0.3
Caffeic acid 27.6 ± 20.7 53.5 ± 24.4 n.d. n.d. $$$ n.d. n.d. n.d. n.d.
Ferulic acid 7.2 ± 3.0 6.5 ± 2.9 0.12 ± 0.02 0.14 ± 0.03 0.28 ± 0.05 0.50 ± 0.16 0.02 ± 0.02 0.09 ± 0.05
Ferulic acid sulphate 10.1 ± 5.6 12.4 ± 5.3 n.d. * n.d. n.d. 0.35 ± 0.10 * n.d. n.d. $
Phenylacetic Acid Derivatives
2-(Phenyl)acetic acid 3039 ± 1541 1209 ± 225 87.4 ± 20.8 59.0 ± 16.0 $$ 117 ± 27.8 87.8 ± 15.9 38.1 ± 7.7 9.2 ± 2.6
2-(Hydroxyphenyl)acetic acid 1 197 ± 124 291.0 ± 37.3 7.0 ± 1.5 * 19.3 ± 3.8 $ 31.9 ± 5.3 51.1 ± 11.7 3.7 ± 0.6 * 8.2 ± 2.1
Catechol Derivatives
Catechol sulphate 8.32 ± 1.46 7.26 ± 3.25 n.d. *** 0.41 ± 0.14 0.46 ± 0.17 0.71 ± 0.29 n.d. 0.19 ± 0.12
4-methyl catechol sulphate 1 5.65 ± 2.21 3.51 ± 1.38 n.d. * 0.01 ± 0.01 0.18 ± 0.12 0.16 ± 0.11 n.d. n.d.
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Table 3. Cont.
4th Week 9th Week
LS LSB HS HSB LS LSB HS HSB
Propionic acid Derivatives
3-(Phenyl)propionic acid n.d. 3.3 ± 1.7 1.0 ± 0.3 2.3 ± 0.3 2.7 ± 0.9 3.2 ± 1.0 1.2 ±0.4 1.4 ± 0.3
3-(hydroxyphenyl) propionic acid 1 55.0 ± 17.9 353 ± 125 2.7 ± 0.4 10.0 ± 2.3 n.d. 53.7 ± 12.1 0.87 ± 0.55 5.9 ± 1.7 $$$
(Hydroxyphenyl)propionic acid sulphate 1 62.1 ± 35.2 299 ± 128 n.d. ** 0.66 ± 0.23 10.0 ± 4.3 11.6 ± 3.8 n.d. 0.20 ± 0.13
Dihydroferrulic acid 4.2 ± 2.7 3.2 ± 1.2 n.d. n.d. $ 0.28 ± 0.08 0.39 ± 0.16 n.d. n.d.
Hippuric Acid Derivatives
Hippuric acid 546 ± 326 1567 ± 701 0.41 ± 0.27 ** 2.9 ± 0.5 2.4 ± 0.6 64.9 ± 21.4 0.48 ± 0.30 0.94 ± 0.39 $$
* p < 0.05, ** p < 0.01, *** p < 0.001 versus LS; $ p < 0.05, $$ p < 0.01, $$$ p < 0.001 vs. LSB; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. HS; n.d.: not detected; 1 It is possible to have more than one
isomer for this compound that is not possible to distinguish by the MS/MS.
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Table 4. (Poly)phenol metabolites exclusively identified in faeces of the rats fed a LSB and HSB diet at
4 and 9 weeks of trial. Results are represented in µmol/kg fresh faeces as the mean ± SEM of values at 4
and 9 weeks of diet for six rats in the LS and LSB groups, for eight rats in the HS group and 12 rats in
the HSB group.
4th Week 9th Week
LSB HSB LSB HSB
Benzoic Acid Derivatives
Protocatechuic acid 73.2 ± 22.2 *** 6.6 ± 1.2 ### n.d. n.d.
4-O-methyl gallic acid  10.0 ± 1.3 *** n.d. $$$ 1.7 ± 0.2 ** n.d. $$
Syringic acid 19.5 ± 2.6 *** 2.8 ± 0.5 ## 4.5 ± 0.8 ** 1.6 ± 0.3
Propionic Acid Derivatives
3-(dihydroxyphenyl) propionic acid  1 n.d. n.d. 1.5 ± 0.8 ** n.d. $$
Valeric Acid Derivatives
5-(Hydroxyphenyl)valeric acid 1 84.9 ± 16.8 *** 3.9 ± 0.7 # 25.0 ± 9.2*** 1.7 ± 0.5
Flavanols Derivatives
Catechin n.d. 1.7 ± 0.6 0.34 ± 0.23 6.5 ± 4.2 #
Epicatechin 13.0 ± 8.5 7.1 ± 2.4 ### n.d. 3.3 ± 0.9
Diarylpropan-2-ol 1 2.9 ± 1.3 0.22 ± 0.15 0.94 ± 0.37 * 0.21 ± 0.14
 Metabolites exclusively excreted in faeces of LSB rats. * p < 0.05, ** p < 0.01, *** p < 0.001 versus LS; $$ p < 0.01,
$$$ p < 0.001 vs. LSB; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. HS; n.d.: not detected; 1 It is possible to have more
than one isomer for this compound that is not possible to distinguish by the MS/MS.
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Figure 2. Anthocyanins identified exclusively in faeces of rats fed a LSB and HSB diet at 4 and 9 weeks of trial. Results are represented (nmol/kg fresh faeces) as the
mean ± SEM of values at 4 and 9 weeks of diet for six rats in the LSB group and 12 rats in the HSB group.
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3.6. Salt and Berry Consumption Alter Gut Microbiota Composition
Besides assessing the metabolic fate of (poly)phenols after a chronic ingestion of berries, it is also
important to evaluate how this supplementation affects the composition of gut microbiota, which
ultimately affects the (poly)phenol metabolism. To investigate how the composition of gut microbiota
is affected by the development of a hypertensive phenotype associated with the consumption of
high-salt diets and also supplemented with berries, we analysed the faecal microbiota composition
and diversity of rats fed with LS, LSB, HS and HSB diets for 9 weeks. The gut microbiota composition
was altered by both the hypertensive scenario induced by the salt content of the diet (perMANOVA,
p = 0.01) as well as the consumption of berries (perMANOVA, p = 0.004). Ordination of samples using
Principal Coordinate Analysis (PCoA, Bray–Curtis distances) revealed clustering of samples according
to diet (ANOSIM, p = 0.001) (Figure 4A). The results showed that samples clustered along the first
principal coordinate according to the consumption of berries (ANOSIM, p = 0.001) and along the
second principal coordinate according to the dietary salt intake (ANOSIM, p = 0.029). This indicates
that both salt and the consumption of berries led to marked and reproducible shifts in the composition
of the gut microbiota (Figure 4A).
Alpha diversity analysis revealed that the operational taxonomic unit (OTU) richness (Figure 4B,
left panel) was affected by feed regime (ANOVA, p = 0.0152), with the consumption of berries increasing
microbiota richness (p = 0.02). Shannon diversity index (Figure 4B, right panel), which incorporates
both richness and evenness of the abundance of OTUs, showed a trend towards increasing diversity
with the consumption of berries. However, this is not statistically significant. This indicates that berry
consumption promotes the expansion of additional bacterial species (OTUs).
At the phylogenetic level, the consumption of berries led to an expansion of the phylum
Bacteroidetes and a decrease in Firmicutes when supplemented in both LS and HS diets (p = 0.0004
and p = 0.022, respectively) (Figure 4C). Interestingly, Proteobacteria were elevated in the HS diet, but
the consumption of berries led to a reduction in their abundance (p = 0.033).
In order to better understand the impact of salt-induced hypertension and berry supplementation
on the microbial community, we studied the correlation between the exposure to the diet and the
taxonomic composition at the family level (Figure 4D). The Bacteroidetes family’s Bacteroidaceae and
S24-7 were elevated due to the consumption of berries (p = 0.029 and p = 0.003, respectively). A sharp
increase in Ruminococcaceae when berries are supplemented in both LS and HS diets was observed
(Figure 4D). Also, the family Erysipelotrichaceae was increased when the animals were fed a high-salt
diet, but the consumption of berries led to a reduction in this group (p = 0.01) (Figure 4D).
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3.7. Salt and Berries Affect SCFA in Faeces
SCFAs are the end products of microbial fermentation and perform diverse functional roles that
affect the host’s physiology, and have been linked to blood pressure regulation [42–46]. To examine
whether the composition of the rat SCFA was altered as a result of the differential diet, faecal SCFAs
were quantitated by gas chromatography.
The analysis of the main SCFAs generated by gut microbial fermentation (butyric, propionic, and
branched acids) did not show significant changes with any of the interventions (Figure 5). However,
acetate was elevated in the faeces of HS rats (42.9 ± 13.6 mol/g faeces), and the introduction of berries
in the diet (HSB) promoted a significant decrease in acetate (17.5 ± 0.9 mol/g faeces) production and
excretion in faeces.
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4. Discussion
The deleterious effect of a high-salt diet on cardiovascular health is driven by arterial hypertension
and is associated with increased morbidity and mortality [5,47]. Numerous epidemiological studies
have shown that a high intake of fruit and vegetables, which are rich sources of (poly)phenols, is
associated with a lower incidence of cardiovascular mortality [9] and reduced blood pressure [48,49].
However, is not known how salt or the salt induced pathology can affect the absorption and metabolism
of (poly)phenols which ultimately can alter the biological potential for modulating CVDs.
Moreover, there is increasing evidence that the activity and composition of the gut microbiota is
implicated in many disease states, particularly in CVDs, in response to treatment [50]. Additionally,
the composition of the gut microbiota strongly depends of diet [51–54] and plays a pivotal role on
(poly)phenol metabolism [55–57].
To understand the impact of salt or the salt induced alterations in the metabolic fate of a
(poly)phenol-enriched diet and gut microbiota composition, rats were fed a diet with or without salt or
berries for 9 weeks. We used the Dahl/SS rat model, which is a validated chronic model of salt sensitive
hypertension [58] mimicking the pathophysiological evolution of hypertension [59]. It was previously
demonstrated for the same animals that the daily consumption of this berry mixture improved the
survival, renal function, blood pressure and normalised the body weight of animals consuming a
high-salt diet. In addition, a prophylactic effect was observed at the level of cardiac hypertrophy
and dysfunction, tissue cohesion and cardiomyocyte hypertrophy [21]. Despite the beneficial effects
observed it was unclear how berry components are absorbed, distributed, metabolised and excreted in
these animals. The bioavailability and activity of (poly)phenols depend on diet, food matrices and
interactions with other food constituents and while some food matrices can enhance their availability,
others can reduce it [60,61]. The diets given to the rats were characterised by HPLC–MS in order to
understand whether a high-salt content can influence the composition and release of the (poly)phenols
from diet in vivo. HPLC–MS data revealed a great complexity and diversity of compounds present in
the diets and demonstrated that the main factor that distinguishes the diets is the presence of berries
and that salt does not interfere in the release of aglycones. Indeed, only three metabolites appeared to
be significantly different (ANOVA) between high-salt berries and low-salt berries, which means that
the presence of salt does not affect significantly the release of the aglycones from the food matrix.
Besides anthocyanins, which are the most abundant (poly)phenolic compounds present in
our berry mixture [29], most of the metabolites found in urine and faeces were conjugated or
non-conjugated phenolic acid derivatives. Only 6 of the metabolites are flavonoid derivatives,
more specifically flavanols (catechin glucuronide, methyl-O-catechin sulphate, methyl-O-catechin
glucuronide, epicatechin glucuronide and methyl-O-epicatechin sulphate).
The most abundant phenolic acid compound found at weeks 4 and 9 in urine and faeces was
hippuric acid, followed by some hydroxycinnamic acids, and propionic acid derivatives. The majority
of the compounds increased in urine from week 4 to week 9. This is in accordance with a prior study
in humans that found a significant increase in the levels of p-coumaric acid and 3-hydroxyphenylacetic
acid in urine after 8 weeks berry consumption [62]. Other studies using other sources of (poly)phenols,
such as green tea, also report a significant increase in some urinary catechin metabolites, which is also
in agreement with our results.
Cyanidin, the major anthocyanin present in our berry mixture, can be converted by the gut
microbiota into benzaldehydes and small phenolic acids such as propionic, phenylacetic and some
benzoic acids such as protocatechuic acid [63–67]. It is also reported that cyanidin can be the precursor
to phloroglucinol, resorcinol, and pyrogallol [64]. These compounds can be sulphated and methylated
or dehydroxylated, generating catechol [68] which, being a substrate for sulphatases, will increase
the amount of catechol sulphate. These metabolites were detected in urine and plasma of human
volunteers that consumed the same berry mixture that was given in this work to the rats [29,69].
The fact that cyanidin was the major anthocyanin present in the berry mixture, and its degradation
products resulting from the gastro-intestinal digestion are phenolic acids, may explain the reason why
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phenolic acids are the most represented class of compounds that was found in urine and faeces of the
animals used in this trial.
At week 4 of the diet, the urine samples of animals fed high concentrations of salt showed an
increase in the release of the majority of the compounds (including anthocyanins), with the exception
of some ferulic acid derivatives. By week 9 these effects were not as pronounced. However, after
the chronic intake of salt those animals showed a decrease in the urinary excretion of some catechin
derivatives. Animals fed salt enriched diets excreted lower amounts of ferulic acid derivatives regardless
of the dietary supplementation with berries, meaning that the excretion rates of these compounds
were affected in animals subjected to the salt-enriched diet. These compounds can result from the
degradation of caffeoylquinic acids, which are also present in higher amounts in the berry mixture
used in this trial [29]. Most of the caffeoylquinic acids arrive in the colon intact [55,70], where abundant
esterases from colonic microbiota will hydrolyse the phenolic-quinic acid linkage [71]. Released
phenolic acids are readily converted by the microbiota to the dihydro forms, such as dihydroferulic
acid and 3-(dihydroxyphenyl) propionic acid, or can undergo phase II metabolism, namely sulphation
and glucuronidation [72]. Dihydroferulic acid can be converted to vanillic acid [73] followed by phase
II metabolism. Simpler phenolic acids, like the ones found in our study, such as gallic acid can undergo
phase I and II metabolism, which will generate compounds such as pyrogallol [68], hippuric acid [63],
syringic acid [74], gallic acid sulphate, and 4-O-methylgallic acid sulphate [69], also present in urine
and faeces of the rats in this animal trial.
Moreover, Feliciano et al. hypothesised that peonidin present in higher amount in a cranberry
juice given to humans, and also present in our berry mixture, could also lead to the formation of
vanillic and ferulic acids [75] which is in agreement with our results.
Despite being present in all 4 groups, hippuric acid was excreted at higher amounts in urine
and faeces of rats that consumed berries, particularly in the urine of HSB rats. These results are in
agreement with previous studies where authors demonstrated that hippuric acid was significantly
associated with blueberry and cranberry intake [75,76], a 12 week period of bilberry consumption [77],
and with a high intake of a (poly)phenol enriched diet for 8 weeks [78]. This metabolite originates
from the conjugation of colonic benzoic acids with glycine in the liver (amino acid metabolism) [61],
which indicates that the presence of hippuric acid in LS and HS urines rats could be associated to other
sources such as amino acid metabolism. This may also be true for other endogenous metabolites such
as hydroxyphenylacetic acid, which can be derived from other sources than phenolic compounds.
Metabolite excretion in faeces at week 9 was lower than at week 4, which is in contrast to the
pattern observed in urine samples. The faecal excretion of (poly)phenol metabolites was in the range of
µmol/kg, and the majority of the ingested (poly)phenols are known to be transformed or degraded in
the gut [79]. After 9 weeks of dietary intervention, the excretion of metabolites in the faeces was reduced
suggesting that metabolism and absorption increased which could be associated with the increases
detected in metabolite levels in urine. On the other hand, anthocyanins excretion was higher at the
end of the trial as observed on both faecal and urine samples, especially for the animals consuming a
salt-enriched diet. This high excretion rate is related with the low absorption of anthocyanins and
hence their low bioavailability into the blood stream [64,80].
In order to evaluate the effects of a (poly)phenol enriched diet in the composition of gut microbiota
and provide a link between bioactive metabolites of (poly)phenols and gut microbiota, we analysed
the composition of the rat faecal microbiota over a period of 9 weeks. The faecal microbiota analysis
clearly demonstrated that both the salt enriched diets and the consumption of berries, can induce
changes in the microbiota and SCFA levels, two factors that have been implicated in the maintenance
of a healthy gut physiology. This is in agreement with previous works showing that high-salt diet
alters gut microbiota [81]. Despite no statistical differences in Lactobacillus species observed in our
study, we observed a trend for increased Lactobacillicaceae in HS and HSB diets. Interestingly, a recent
study with healthy male mice suggested that dietary salt increases blood pressure partly by affecting
their gut microbiome, particularly by depleting Lactobacilus murinus [81]. Consequently, treatment
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with L. murinus prevented salt induced hypertension. It has also been demonstrated in a pilot study
in humans that a moderate high-salt challenge reduced intestinal survival of Lactobacillus spp. and
increased blood pressure [81]. Moreover, in a study conducted with the Dahl/SS rats, the authors
demonstrated that these rats have a different microbiota than salt-resistant rats [82].
Furthermore, the consumption of (poly)phenol-rich diets has also been shown to have impacts on
gut microbial population dynamics and gastro-intestinal tract health [83–86]. Lacombe et al., showed
that lowbush wild blueberries had the potential to modify rat gut microbiota by decreasing the relative
abundance of the genera Lactobacillus and Enterococcus, and increasing the relative abundance of the
phylum Actinobacteria [83]. Moreover, in human volunteers, a six-week crossover dietary intervention
demonstrated the potential of wild blueberries in modulating the intestinal microbiota. Bifidobacterium
spp. significantly increased following blueberry consumption [86].
In our study, we demonstrate that members of the Bacteroidetes phylum increased due to the
consumption of berries. Members of this phylum are versatile degraders of complex polysaccharides
and plant compounds [87] and their increased abundance may be due to compounds present in
the berries that support their growth. Firmicutes possess a disproportionately smaller number of
glycan degrading enzymes than Bacteroidetes, and it might be hypothesised that intake of different
(poly)phenols might reshape the gut microbiota [88], promoting the increase in Bacteroidetes as we
observed in our study.
Moreover, we saw an increase in Bacteroidaceae family in rats fed a berry-enriched diet, which was
also reported in other studies with fruit-enriched diets. For example, rats supplemented with apple
fibre showed an increase in Bacteroidaceae family in almost one-log10 higher counts than in in faeces of
control rats [89].
The consumption of berries also promoted an increase in the S24-7 family in faecal samples from
LSB and HSB rats, these are members of uncultured Bacteroidales that have been recently associated
with the degradation of specific carbohydrates [90]. Differences in the abundance of S24-7 family
are associated with different environmental conditions, e.g., increased abundance in mice fed with
cherries [91], diabetes-sensitive mice fed a high-fat diet [92], in rats with a high-salt diet [82] and
following remission of colitis in a mouse model [93]. However, the metabolic functions and the
consequences of these differences in abundance of S24-7 are still unknown as they remain uncultured.
However, genomic studies have been undertaken recently. In this study, we demonstrate for the first
time that the consumption of berries has an impact on their abundance, as subsequent studies are
necessary to elucidate their role in berry (poly)phenol metabolism.
Interestingly, the berry diet suppressed some changes in the microbiota caused by the high-salt
diet such as the expansion of the phylum Proteobacteria and Erysipelotrichaceae family. There is strong
evidence supporting an association between Erysipelotrichaceae and host lipid metabolism, warranting
additional investigation into the metabolic profiles of these organisms, and the influence they have
on the host [94]. Specific taxa within Erysipelotrichaceae have been correlated with inflammation [95],
while others are highly immunogenic [96]. This highlights the importance of characterizing this
bacterial family further which may eventually provide promising microbial targets to combat metabolic
disorders. In our study, we found that the consumption of berries decreased the expansion of
Erysipelotrichaceae promoted by the salt diet. A similar trend was observed in a study where treatment
with quercetin attenuated the increase in Firmicutes/Bacteroidetes ratio in high-fat sucrose-diet-fed
rats and significantly reduced the abundance of Erysipelotrichaceae, which is closely related to the
consumption of Western diets [97].
SCFAs are the main fermentation product of gut microbiota and perform diverse functional roles
that affect the host’s physiology, namely regulation of the blood pressure [98]. We investigated whether
the faecal SCFA profiles changed due to the different diets. Only acetate was significantly different
between groups. Acetate was elevated in the faeces of HS rats and the introduction of berries in
the diet (HSB) promoted a significant decrease in the production of acetate. Though not statistically
significant, the relative abundance of Ruminococaceae family was lower in the faeces of HS than in HSB
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rats. This family uses acetate to produce butyrate [99], and since they are present in lower abundance in
HS faeces, they will consume less acetate thus explaining the SCFA accumulation in faeces. In contrast,
Ruminococaceae family are more abundant in HSB rats where they consume acetate decreasing the
amounts detected in faeces. The fact that SCFA measurements were conducted ex vivo in faeces does
not reflect the overall production of SCFA. Rats are caecum fermenters and most of these compounds
(95%–99%) are already absorbed in the large intestine. However, our work only accounts for the faecal
SCFA excreted, which explains why only acetate is significantly altered.
Recent findings have demonstrated that changes in blood pressure are often coordinated with
expected changes in SCFAs. One way that SCFAs can influence host cells is by interacting with host
G-protein-coupled receptors (GPCRs), including GPR41, GPR43 and olfactory receptor 78 (Olfr78) [42]
and by inducing host cell death [100]. SCFAs can stimulate the regulation pathways of GPCRs in
order to affect renin secretion and therefore blood pressure [45,101]. In a study conducted with
GPR41 knockout mice, these animals developed elevated systolic blood pressure when compared
with wild-type mice, through the regulation of the endothelial GPR41 by the SCFA [102]. Moreover,
propionate is a SCFA that can induce vasodilation and produce an acute hypotensive response in
mice through modulation of Olfr78 and GPR41 activity [103]. Another study demonstrated that
stimulation of GPR41 resulted in a reduction of the hypotensive response, and this effect could be
mitigated by stimulating Olfr78 [45]. Additionally, the authors described that antibiotic treatment
altered composition of gut microbiota and also increased blood pressure in Olfr78 knockout mice [45].
However, the details and intricacies of these interactions are not yet fully understood and will greatly
benefit from further studies.
As the microbiota is thought to be important in mediating the effects of dietary salt [81,82] by
promoting an increase in blood pressure either in animals and humans, it is possible that the effects
of berry consumption by Dahl/SS rats on reducing the harmful effects of a high-salt diet are at least
partially due to its ability to modify the gut microbiota. Further studies are important to uncover the
main contributors for the beneficial effects of (poly)phenol consumption in this two-way interaction
between (poly)phenols and gut microbiota: a specific gut microbial community associated with
(poly)phenol metabolism, a specific microbial metabolite(s) produced, or both factors acting in an
additive/synergistic manner [104].
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/11/2634/s1,
Figure S1—Total ion chromatograms of non-hydrolysed HSB, LSB, HS and LS diet extracts acquired in ESI positive
mode (A) and ESI negative mode (B); Figure S2: Impact of salt and berry supplementation in the composition
of the diets. HPLC–MS (negative and positive mode) data of (A) non-hydrolysed samples and (B) hydrolysed
samples was processed by means of a Principal Component Analysis (PCA). N = 3. Samples clustering is
indicated; Supplementary Figure S3—Total ion chromatograms of hydrolysed HSB, LSB, HS and LS diet extracts
acquired in ESI positive mode (A) and ESI negative mode (B); Figure S4: Berries improve body weight and
blood pressure in Dahl-salt sensitive rats. (A) Serial data on body weight. Data represents the mean ± S.E.M.
* p < 0.05 vs. LS; $ p < 0.05 vs. LSB; # p < 0.05 vs. HS. N = 6 LS, N = 6 LSB, N = 8 HS, N = 13 HSB. (C)
SBP measurement by tail cuff method. Data represents mean ± S.E.M. * p < 0.05 vs. LS; $ p < 0.05 vs. LSB;
# p < 0.05 vs. HS. N = 6 LS, N = 6 LSB, N = 8 HS. N = 13 HSB. This animal trial was also used for study
the cardioprotective mechanisms, and therefore this data was also presented in a preceding paper published
in Oudot C. et al., Nutritional Biochemistry, doi:10.1016/j.jnutbio.2019.01.001 (2019); Table S1: Optimised SRM
conditions for analysing the phenolic compounds determined in urine and faeces samples by UPLC–MS/MS;
Table S2: Proximate composition of diets was determined based on the standard methods of the Association of
Official Analytical Chemists (AOAC); Table S3: Proximate composition of berry mixture was determined based on
the standard methods of the Association of Official Analytical Chemists (AOAC); Table S4: List of tentatively
annotated metabolites present in the chemical analysis in ESI positive mode of the different non-hydrolysed
diets. Analysis of variance results comparing berry diets with either high salt or low salt composition include
significance level (F pr.), grand mean, high salt mean, low salt mean and standard error of means (SEM) for
each metabolite. Identification level corresponds to the levels of confidence on the annotation of the metabolite:
1—Annotation based on two or more orthogonal properties with an authentic chemical standard analysed under
identical analytical conditions; 2—based upon physicochemical properties and/or spectral similarity with public
commercial spectral libraries, without reference to authentic chemical standards; 3—based upon characteristic
physicochemical properties of a chemical class of compounds, or by spectral similarity to know compounds of a
chemical class; 4—unidentified and unclassified, these metabolites can still be differentiated and quantified based
upon spectral data; Table S5: List of tentatively annotated metabolites present in the chemical analysis in ESI
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negative mode of the different non-hydrolysed diets. Analysis of variance results comparing berry diets with
either high salt or low salt composition include significance level (F pr.), grand mean, high salt mean, low salt
mean and standard error of means (SEM) for each metabolite. Identification level corresponds to the levels of
confidence on the annotation of the metabolite: 1–Annotation based on two or more orthogonal properties with
an authentic chemical standard analysed under identical analytical conditions; 2—based upon physicochemical
properties and/or spectral similarity with public commercial spectral libraries, without reference to authentic
chemical standards; 3—based upon characteristic physicochemical properties of a chemical class of compounds, or
by spectral similarity to know compounds of a chemical class; 4—unidentified and unclassified, these metabolites
can still be differentiated and quantified based upon spectral data; Table S6—Characterization and quantification
of anthocyanins in the berry mixture. Anthocyanins were analysed by UPLC–MS/MS. The analytical column was
Acquity BEH UPLC (100 × 2.1 mm, 1.7 µm), the mobile phase was 10% acetic acid (eluent A) and acetonitrile
(eluent B) [26]. The injection volume was 2.5 µL and the flow rate was 0.3 mL/min; Table S7: Characterization
and quantification of main aglycones in the berry mixture, after enzymatic hydrolysis using HPLC-DAD relative
to authentic standards as previously described [60]; Table S8: List of tentatively annotated metabolites present
in the chemical analysis in ESI positive mode of the different hydrolysed diets. Analysis of variance results
comparing berry diets with either high salt or low salt composition include significance level (F pr.), grand
mean, high salt mean, low salt mean and standard error of means (SEM.) for each metabolite. Identification
level corresponds to the levels of confidence on the annotation of the metabolite: 1—Annotation based on two or
more orthogonal properties with an authentic chemical standard analysed under identical analytical conditions;
2—based upon physicochemical properties and/or spectral similarity with public commercial spectral libraries,
without reference to authentic chemical standards; 3—based upon characteristic physicochemical properties of a
chemical class of compounds, or by spectral similarity to know compounds of a chemical class; 4—unidentified
and unclassified, these metabolites can still be differentiated and quantified based upon spectral data; Table S9:
List of tentatively annotated metabolites present in the chemical analysis in ESI negative mode of the different
hydrolysed diets. Analysis of variance results comparing berry diets with either high salt or low salt composition
include significance level (F pr.), grand mean, high salt mean, low salt mean and standard error of means (SEM)
for each metabolite. Identification level corresponds to the levels of confidence on the annotation of the metabolite:
1—Annotation based on two or more orthogonal properties with an authentic chemical standard analysed under
identical analytical conditions; 2—based upon physicochemical properties and/or spectral similarity with public
commercial spectral libraries, without reference to authentic chemical standards; 3—based upon characteristic
physicochemical properties of a chemical class of compounds, or by spectral similarity to know compounds of a
chemical class; 4—unidentified and unclassified, these metabolites can still be differentiated and quantified based
upon spectral data.
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